rucaparib (as rucaparib camsylate) 300 MG Oral Tablet

RxCUI: 1862584
RxNorm name: rucaparib (as rucaparib camsylate) 300 MG Oral Tablet
Display name: rucaparib (as rucaparib camsylate) 300 MG Oral Tablet
Full name: rucaparib (as rucaparib camsylate) 300 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rubraca	RUCAPARIB	pharmaand GmbH	0295d202-1cfe-7659-e063-6294a90a476e	2025-12-31	Warnings, Adverse reactions	Exact identifier rxcui: 1862584

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
0295d202-1cfe-7659-e063-6294a90a476e	rucaparib (as rucaparib camsylate) 300 MG Oral Tablet	SY	19	These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 2016	20251231
0295d202-1cfe-7659-e063-6294a90a476e	rucaparib 300 MG Oral Tablet	SCD	19	These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 2016	20251231
0295d202-1cfe-7659-e063-6294a90a476e	rucaparib 300 MG Oral Tablet	PSN	19	These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 2016	20251231